USANA Health Sciences, Inc. (USNA) Shares Bought by TIAA CREF Investment Management LLC

TIAA CREF Investment Management LLC raised its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 28.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 118,066 shares of the company’s stock after acquiring an additional 26,152 shares during the period. TIAA CREF Investment Management LLC owned 0.47% of USANA Health Sciences worth $7,568,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in USNA. American International Group Inc. boosted its stake in shares of USANA Health Sciences by 7.1% during the first quarter. American International Group Inc. now owns 6,392 shares of the company’s stock worth $368,000 after buying an additional 422 shares during the period. Schroder Investment Management Group boosted its stake in shares of USANA Health Sciences by 9.0% during the second quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock worth $36,734,000 after buying an additional 47,448 shares during the period. Prudential Financial Inc. boosted its stake in shares of USANA Health Sciences by 22.4% during the first quarter. Prudential Financial Inc. now owns 69,763 shares of the company’s stock worth $4,019,000 after buying an additional 12,757 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of USANA Health Sciences by 1.2% during the first quarter. JPMorgan Chase & Co. now owns 16,044 shares of the company’s stock worth $924,000 after buying an additional 196 shares during the period. Finally, MARSHALL WACE ASIA Ltd acquired a new stake in shares of USANA Health Sciences during the first quarter worth about $1,436,000. Institutional investors own 44.85% of the company’s stock.

In other news, Director Gilbert A. Fuller sold 1,483 shares of USANA Health Sciences stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $57.67, for a total value of $85,524.61. Following the completion of the transaction, the director now directly owns 1,483 shares of the company’s stock, valued at approximately $85,524.61. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Myron W. Wentz sold 40,000 shares of USANA Health Sciences stock in a transaction dated Tuesday, October 3rd. The shares were sold at an average price of $57.54, for a total transaction of $2,301,600.00. The disclosure for this sale can be found here. Insiders sold a total of 386,340 shares of company stock valued at $22,270,913 over the last ninety days. Company insiders own 53.20% of the company’s stock.

Shares of USANA Health Sciences, Inc. (NYSE:USNA) opened at 60.60 on Wednesday. The stock’s 50 day moving average is $58.09 and its 200 day moving average is $60.18. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $74.72. The firm has a market cap of $1.48 billion, a P/E ratio of 15.74 and a beta of 1.09.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.06 by ($0.08). USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The business had revenue of $257.10 million during the quarter, compared to analyst estimates of $273.61 million. During the same period last year, the firm posted $2.07 earnings per share. The company’s quarterly revenue was down .5% on a year-over-year basis. On average, equities research analysts predict that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current fiscal year.

USANA Health Sciences declared that its board has initiated a share repurchase plan on Tuesday, July 25th that permits the company to buyback $64.60 million in shares. This buyback authorization permits the company to purchase up to 46% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

COPYRIGHT VIOLATION WARNING: This news story was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://sportsperspectives.com/2017/10/11/usana-health-sciences-inc-usna-shares-bought-by-tiaa-cref-investment-management-llc.html.

Several brokerages have recently weighed in on USNA. BidaskClub downgraded shares of USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research note on Monday, July 31st. Pivotal Research decreased their target price on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a research note on Wednesday, July 26th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply